Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality.

Sachdeva M, Busser BW, Temburni S, Jahangiri B, Gautron AS, Maréchal A, Juillerat A, Williams A, Depil S, Duchateau P, Poirot L, Valton J.

Nat Commun. 2019 Nov 13;10(1):5100. doi: 10.1038/s41467-019-13088-3.

2.

TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection.

de Marcken M, Dhaliwal K, Danielsen AC, Gautron AS, Dominguez-Villar M.

Sci Signal. 2019 Oct 29;12(605). pii: eaaw1347. doi: 10.1126/scisignal.aaw1347.

3.

AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease.

Kitz A, de Marcken M, Gautron AS, Mitrovic M, Hafler DA, Dominguez-Villar M.

EMBO Rep. 2019 Aug;20(8):e48624. doi: 10.15252/embr.201948624. No abstract available.

4.

Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy.

Gautron AS, Juillerat A, Guyot V, Filhol JM, Dessez E, Duclert A, Duchateau P, Poirot L.

Mol Ther Nucleic Acids. 2017 Dec 15;9:312-321. doi: 10.1016/j.omtn.2017.10.005. Epub 2017 Oct 14.

5.

AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease.

Kitz A, de Marcken M, Gautron AS, Mitrovic M, Hafler DA, Dominguez-Villar M.

EMBO Rep. 2016 Aug;17(8):1169-83. doi: 10.15252/embr.201541905. Epub 2016 Jun 16. Erratum in: EMBO Rep. 2019 Aug;20(8):e48624.

6.

TLR7 induces anergy in human CD4(+) T cells.

Dominguez-Villar M, Gautron AS, de Marcken M, Keller MJ, Hafler DA.

Nat Immunol. 2015 Jan;16(1):118-28. doi: 10.1038/ni.3036. Epub 2014 Nov 17.

7.

Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.

Gautron AS, Dominguez-Villar M, de Marcken M, Hafler DA.

Eur J Immunol. 2014 Sep;44(9):2703-2711. doi: 10.1002/eji.201344392. Epub 2014 Jun 16.

8.

NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes.

Simoni Y, Gautron AS, Beaudoin L, Bui LC, Michel ML, Coumoul X, Eberl G, Leite-de-Moraes M, Lehuen A.

Eur J Immunol. 2011 Dec;41(12):3574-85. doi: 10.1002/eji.201141751. Epub 2011 Nov 10.

9.

NKT and tolerance.

Diana J, Beaudoin L, Gautron AS, Lehuen A.

Methods Mol Biol. 2011;677:193-206. doi: 10.1007/978-1-60761-869-0_14.

PMID:
20941612
10.

Invariant NKT cells in adrenoleukodystrophy patients and mice.

Gautron AS, Giquel B, Beaudoin L, Autrusseau E, Speak A, Platt F, Kemp S, Pujol A, Aubourg P, Lehuen A.

J Neuroimmunol. 2010 Dec 15;229(1-2):204-11. doi: 10.1016/j.jneuroim.2010.09.003.

PMID:
20920830
11.

NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner.

Diana J, Griseri T, Lagaye S, Beaudoin L, Autrusseau E, Gautron AS, Tomkiewicz C, Herbelin A, Barouki R, von Herrath M, Dalod M, Lehuen A.

Immunity. 2009 Feb 20;30(2):289-99. doi: 10.1016/j.immuni.2008.12.017. Epub 2009 Feb 12.

12.

Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner.

Mars LT, Gautron AS, Novak J, Beaudoin L, Diana J, Liblau RS, Lehuen A.

J Immunol. 2008 Aug 15;181(4):2321-9.

Supplemental Content

Loading ...
Support Center